Interferon-independent STING signaling promotes resistance to HSV-1 in vivo.
Lívia H YamashiroStephen C WilsonHuntly M MorrisonVasiliki KaralisJing-Yi J ChungKatherine J ChenHelen S BateupMoriah L SzparaAngus Y LeeJeffery S CoxRussell E VancePublished in: Nature communications (2020)
The Stimulator of Interferon Genes (STING) pathway initiates potent immune responses upon recognition of DNA. To initiate signaling, serine 365 (S365) in the C-terminal tail (CTT) of STING is phosphorylated, leading to induction of type I interferons (IFNs). Additionally, evolutionary conserved responses such as autophagy also occur downstream of STING, but their relative importance during in vivo infections remains unclear. Here we report that mice harboring a serine 365-to-alanine (S365A) mutation in STING are unexpectedly resistant to Herpes Simplex Virus (HSV)-1, despite lacking STING-induced type I IFN responses. By contrast, resistance to HSV-1 is abolished in mice lacking the STING CTT, suggesting that the STING CTT initiates protective responses against HSV-1, independently of type I IFNs. Interestingly, we find that STING-induced autophagy is a CTT- and TBK1-dependent but IRF3-independent process that is conserved in the STING S365A mice. Thus, interferon-independent functions of STING mediate STING-dependent antiviral responses in vivo.
Keyphrases
- herpes simplex virus
- dendritic cells
- immune response
- signaling pathway
- oxidative stress
- cell death
- transcription factor
- genome wide
- gene expression
- metabolic syndrome
- magnetic resonance imaging
- skeletal muscle
- high fat diet induced
- insulin resistance
- high glucose
- computed tomography
- inflammatory response
- single molecule
- diabetic rats
- adipose tissue
- endothelial cells
- stress induced
- cell free